Tag: Vaccines
Two-Dose Novavax Vaccine Protects Against SARS-CoV-2 Infection
Vaccine efficacy in adults was 89.7 percent overall, 86.3 percent against B.1.1.7 (alpha) variant, and 96.4 percent against non-B.1.1.7 variants
Just 20 States Reached Biden’s July 4 Vaccination Goal
Parts of the South, Southwest, and Midwest starting to see surges, particularly Florida, with about 17 percent of all new cases reported there
Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients
Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine
Physician’s Briefing Weekly Coronavirus Roundup
J&J Vaccine Guards Against Delta Variant, Company Says
Although there was a slight drop in potency against the Delta variant, vaccine was more effective against the Delta variant than the Beta variant
mRNA Vaccines Effectively Prevent SARS-CoV-2 in Adults in Real-World Setting
For those with SARS-CoV-2 infection, vaccinated participants had lower mean viral load, risk of febrile symptoms, illness duration
Most Americans Who Wanted COVID-19 Vaccine Have Already Gotten One
Only 3 percent of those who have not been vaccinated said they plan to do so as soon as they can
Many Young Cancer Survivors Report COVID-19 Vaccine Hesitancy
37.1 percent of adolescent and young adult cancer survivors report vaccine hesitancy; higher odds of hesitancy for females
Seven Cases of Guillain-Barré Noted After COVID-19 Vaccine in India
Second study describes four cases, which occurred 11 to 22 days after vaccination with COVID-19 Oxford-AstraZeneca vaccine
